Abstract
After defining the drug class of β-adrenergic blocking agents, general aspects for clinical use of β-blockers are discussed, namely absorption, distribution, metabolism, elimination, correlation between clinical response and drug disposition, drug interactions, and influence of disease on drug response and disposition. Pharmacokinetic data for the following β-blockers were retrieved from the literature: acebutolol, alprenolol, atenolol, labetalol, metoprolol, nadolol oxprenolol, penbutolol, pindolol, practolol, propranolol sotalol, talinolol, timolol, and tolamalol. Those pharmacokinetic parameters which were not listed in the original literature were calculated. The use of pharmacokinetic parameters of β-blockers for clinical application is discussed.
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference73 articles.
1. The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory
2. Vertes V. The rationale for individualized treatment of essential hypertension. Searle: Clinical Seminars in Cardiovascular Therapy. San Juan, PR: Searle and Co., 1977: 13.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Stereochemische Irrwege in der Pharmakotherapie;DMW - Deutsche Medizinische Wochenschrift;2008-03-25
2. Review : Sotalol: Current Status and Expanding Indications;Journal of Cardiovascular Pharmacology and Therapeutics;1999-03
3. Literatur;Sotalol Sotalex®;1994
4. Sotalol;Drugs;1993-10
5. Antiarrhythmic Actions of dl-Sotalol in Ventricular and Supraventricular Arrhythmias;Journal of Cardiovascular Pharmacology;1992